Are PBMs Next to be Regulated?
Politicians have long been discussing the cost of prescription drugs, advancing various policy proposals aimed at lowering drug…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2022
US Supreme Court Rejects Massive Cuts to 340B Hospitals
In June, the Supreme Court unanimously rejected massive payment cuts to hospitals under the 340B drug discount program. In the…
HHS OIG Releases Report on MAO Performance
On April 27,2022, the Office of Inspector General of the Department of Health and Human Services (OIG), Office of Evaluations and…
Eli Lilly Found Liable for Defrauding the Medicaid Program
On August 3, 2022, a jury found Eli Lilly liable for underpaying rebates under the Medicaid Drug Rebate Program and ordered the…
Improving Seniors’ Timely Access to Care Act of 2022 Entering Markup Phase
In late July 2022, the United States House of Representatives Ways and Means Committee marked up H.R. 8487, the Improving Seniors’…
Biotronik Reaches Nearly $13 Million Settlement with DOJ Over Alleged False…
On July 22, 2022, the United States Department of Justice (DOJ) announced a $12.95 million settlement with Biotronik Inc., a…
CMS Announces Enhancing Oncology Model Successor to Oncology Care Model
In June, the Centers for Medicare & Medicaid Services (CMS) announced the Enhancing Oncology Model, a successor to the…
CMS and FDA Show United Front on Aduhelm Approval and Coverage
Earlier this year, Centers for Medicare and Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure and Food and Drug…
Report Finds that Branded Drug Prices Increased an Average of 5% Last Year
Earlier this year, Iqvia released a report, The Use of Medicines in the U.S. 2022, which outlined some of the usage and spending…
Court Rules in Favor of Three Major Opioid Distributors in West Virginia…
On Monday, July 4, 2022, United States District Court Judge David Faber ruled in favor of three opioid distributors – Amerisource…